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ABSTRACT 
Objective: To assess the leaves of Abrus precatorius had earlier show cognition boosting effect against dementia in rodents. Methods: The 
methanol extract was fractionated into ethyl acetate and aqueous fractions and assessed for its nootropic and learning activi ty in albino 
rodents. The effect of triterpenoids containing ethylacetate soluble fraction of methanol extract significant enha ncement in the retention ability 
of amnesic mice as compared to their respective controls using elevated plus maze and Cook and Weidley’s pole apparatus. Subs equently, the 
extracts were further studied for its in vitro acetylcholinesterase (AChE) inhibitory potential which can correlate with an improvement in 
cholinergic transmission. Piracetam was used as the standard drug while scopolamine hydrobromide served as the amnestic agent. Result: 
A.precatorius ethylacetate (APEA) soluble fraction of leaves produced a significant acquisition, retention and retrieval at dosed 150 and 300 
mg/kg in interoceptive as well as exteroceptive memory models of rodents. While A.precatorius aqueous fraction (APAqs) of methanol extract 
not enhances both the acquisition as well as the retention of memory of learned task when administered at a dose of 300 mg/kg for a period of 
7 days. It was found that APEA fraction potentially inhibits AChE with percentage inhibition of 91.33±0.33. Furthermore, both fraction were 
found safe with no deaths in mice treated orally with 2000 mg/kg. 
Conclusion: APEA showed to be a useful memory restorative agent in the treatment of dementia from the experiments performed.  
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1. INTRODUCTION 
According to a recent National Mental Health survey in India 
approximately 150 million people affect mental disorders 
and need care for their socio-economic burden on society. 
Cognitive impairment is a major neurodegenerative disorder 
affecting large number of population in the world [1]. 
Cognitive-enhancing drugs are well-known compounds or 
supplements recover the patients with neuropsychiatric 
disorders and brain injury. It may also helpful in 
neuropsychiatric disorders such as schizophrenia, 
depression and anxiety disorder [2]. Cognitive-enhancing 
drugs, also recognized as smart drugs, “brain booster,” or 
“nootropic drugs,” are widespread use compound 
responsible for the enhancement of memory performance. 
The term nootropic make two word noos means “mind” and 
tropein mean towards thus drugs belong to the subclass of 
psychotropic agents with that increases mental functions 
including memory, motivation, concentration, and attention 
[3]. Ayurvedic medicines are collected from traditional plant 
native to India and have played an important role in support 
and maintain equilibrium in various phase of human life. 
These include Moringa oleifera [4], Asparagus recemosus [5], 
Bacopa monnieri [6], Convolvulus pluricaulis and Evolvulus 
alsinoides [7],Centella asiatica [8] and Butea frondosa [9] 
have been exploited for the cure and management of acute 
and chronic neurological diseases. A. precatorius, locally 
known as Indian licorice is one of the crucial herbs 
commonly known as belonging to family Fabaceae, native to 
the Indian subcontinents. It is valuable source of unique 
natural compounds with documented biological activity 
against various diseases like anti-bacterial [10], 
immunopotentiating [11, 12], anti-fertility [13, 14], anti-
asthmatic [15], anti-inflammatory [16, 17], anti-diarrhoeal 
[18], anti-diabetic [19, 20], anti-convulsants [21] anti-
oxidant and anti-ulcer activities [22, 23]. 
 Abrus precatorius, locally known as gunchi and rati, is one of 
the most deadly plants known to man. It is a beautiful, 
perennial, deciduous, prickly twining herb with delicate 
feathery leaves with greenish yellow branches [24]. In the 
Indian traditional system leaves of A. precatorius have been 
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used of medicine for the treatment of leucoderma spot, 
itching, urticaria, stomatitis, conjunctivitis, alopecia, 
migraine, lymphomas/ leukemia and dysmenorrhoea [25, 
26]. 
2. MATERIALS AND METHODS 
2.1. Collection of plant material 
Fresh leaves of A. precatorius were collected from the 
medicinal garden of Dr. Harisingh Gour Vishwavidyalaya, 
Sagar, India, in the month November 2016 and washed 
properly and air-dried. The collected plant material was 
authenticated by botanist Dr. P. K. Khare, Professor of 
Botany, Dr. Harisingh Gour Vishwavidyalaya, Sagar, India. A 
herbarium specimen bearing voucher No. Bot/Her/01/2017 
has been deposited in the Department of Botany, Dr. H.S. 
Gour Vishwavidyalaya, Sagar, India. 
2.2. Preparation of extracts 
The shade-dried leaves of the herb ground into a fine 
powder. Powdered material (80 g) was first defatted with 
petroleum ether and extracted successively with methanol in 
Soxhlet’s extractor. Solvent was evaporated in rotary 
evaporator dryness under reduced pressure to obtain the 
methanol extract (4.9 % w/w). The methanol extract was 
further suspended in distilled water and fractioned by using 
ethylacetate to obtained ethylacetate soluble fraction and 
remaining aqueous fraction. Both fraction were concentrated 
under reduced pressure and tested for 
neuropharmacological study.  
2.3. Chemicals 
Piracetam, (Cerecetam, 400 mg/tablet, Intas Laboratories, 
India), Tween 80 (oxford laboratory, India) were used in this 
study. Acetylthiocholine chloride (ATCC) and 5, 5 –dithiobis 
[2- nitrobenzoic acid] (DTNB) were purched from Fine Chem 
Industries Mumbai. Scopolamine hydrobromide and 
Acetylcholinesterase (Electrophorus electricus) were 
obtained from Sigma Ltd. (Mumbai, India). All other reagents 
and chemicals used were of analytical grade. 
2.4. Phytochemical investigation 
The ethylacetate soluble and aqueous fractions are subjected 
to phytochemical analysis using conventional protocol [27]. 
2.5. Animals and housing 
Healthy Swiss albino mice (20–25 g) and Wistar albino rats 
of (180–200 g) of either sex were used for the study. All 
animals were maintained in standard household conditions 
of temperature, light and humidity were used for study. All 
animals were stored in standard cage and maintained at 
(27±2) 0C under 12 h dark/light cycle. They were feed with 
standard rodent diet food and water freely available. Animals 
were fasted overnight prior to drug administration. The 
Institutional Animal Ethical Committee of BTPC, Sagar, India 
(0604/IAEC/2017/252), approved the study. 
2.6. Acute toxicity and effect on gross behavior 
The acute toxicity tests were performed according to the 
OECD-425 guidelines. Both fractions were orally 
administered to Swiss mice (n = 3) of either sex preferred by 
random sampling manner were employed in learning [28]. 
Both fractions were found safe up to the dose of 2000 mg/kg 
and from the results 300 mg/kg was selected as the 
maximum dose for further experimentation on rodent in the 
present study [29].  
 
 
2.7. Administration of the extracts 
In the present investigation, employing various interoceptive 
as well as exteroceptive memory models of rodents. Amnesia 
was provoked in separate group’s mice by scopolamine 
hydrobromide (0.4 mg/kg, i.p.) in interoceptive models. 
Prepared suspensions of the ethylacetate and aqueous 
fractions in distilled water using Tween 80 (0.2% v/v) as the 
suspending agent. Both fractions were administered in dose 
of 150 and 300 mg/kg, p.o., 45 min before the test 
procedures. Control groups were given only the vehicle 
(0.2% v/v Tween 80 solution) in volume equivalent to that of 
the plant fractions. 
2.8. General behavioral tests 
Swiss albino mice were categorized into three groups (6 in 
each group). The aqueous and ethyl acetate soluble fraction 
were administered orally in doses of 300 mg/kg and third 
group received Tween 80 as vehicle. The activities were 
confirmed in the initial phase, observed for body positions, 
locomotion, tremors, rearing, gait, and in the later phase, the 
effect on passivity, pain response grip strength, stereotypy, 
vocalization and righting reflex were noted. 
2.9. Elevated plus maze test 
Elevated plus-maze act as the exteroceptive behavioral 
method to assess memory and learning progression in mice 
by measure transfer latency. The instrument was fabricated 
of two open arms (30 × 05 cm), with central platform (5×5 
cm) and two enclosed arms (30 ×05 × 25 cm). From first day 
to day six, each mouse was put at the end of an open arm, 
facing away from the central display place. Transfer latency 
(TL) was measured as the time duration by the mice to shift 
into any one of the enclosed arms. TL was trace for six 
succeeding days as training section. If the mice did not come 
inside the closed arms within 90 s, it was softly pushed into 
one of the two enclosed arms and TL allotted as 90 s. The 
mice were permitted to explore the maze and then returned 
to its home cage. Memory retention of this learned-task was 
scrutinized 24 h after the 6th day trial. Overnight fasted mice 
were divided into seven groups containing six animals in 
each group. Group I- received only 0.2% v/v Tween 80 
solution volume equivalent. Group II- received scopolamine 
0.4 mg/kg, i.p single dose on day seventh. Group III- 
Piracetam (100 mg/kg, p.o.) was received to mice for 7 
successive days and group IV–VII received APEA and APAqs 
(150 and 300 mg/kg p.o.) were administered orally for 7 
successive days to mice. Retention of this learned-task was 
examined after 24 h (on eighth day) [30, 31].  
2.10. Active avoidance paradigm  
To assess number of active avoidance responses (ARs) using 
Cook and Weidley’s pole instrument [32]. The apparatus 
consisted of Electric shock (20 V, A.C.) was transmitted to the 
grid floor with soundproof chamber and with a buzzer tone. 
Experimental chamber had sliding transparent door, through 
which the animal could well observe. A wooden pole 
attached to internal face of lid of the chamber performed as 
the shock-free zone. The 6 mA foot shock stimuli delivered 
for a period of 10 s on the electrified grid floor for 
assessment of nootropic activity. Rats were previously 
trained to escape the shock by climbing on to wooden pole. 
Beginning trial was carried out by having three trial session 
interspersed with period of 10 s. Only those rats were 
selected in the study, which were responsive to the foot 
shock and could ascend the pole. The rats were divided into 
six groups, containing six animals in each group. Group II 
Piracetam (100 mg/kg, p.o.) was received to rat for 7 
successive days and Group III–VI received APEA and APAqs 
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fractions of leaf (150 and 300 mg/kg p.o.) were administered 
orally for 7 successive days to rat following which the 
training trial (TT) was conducted. Totally 10 trial sessions 
interspersed with a period of 30 s. During every trial rat was 
permitted to walk around the equipment for 10 s, follow by 
50 Hz buzzer tone (conditioned stimulus) followed by the 
foot shock for 10 s. The rat seeking to coalesce the buzzer 
tone with the impede foot shock and keep away from the foot 
shock on hearing the buzzer warning. Avoidance responses 
(AR) mean jump onto the wooden pole, previous to the shock 
phase. One day later, a relearning trial (RT) compiled of 
number of ARs in the 10 trial sessions computed.  
2.11. Assay of AChE enzyme activity by microplate reader  
The determine AChE activity of the extracts were measured 
by using microplate reader based on Ellman’s method [33]. 
The enzyme AChE hydrolyses the substrate acetylthiocholine 
chloride resulting   thiocholine formed due to hydrolysis 
which reacts with Ellman’s reagent (DTNB) to produce a 
yellow 3-thio-2-nitrobenzoic acid anion which can be 
detected at 415 nm. In brief a 96 well plate was placed first 
take 125µL of 3 mmoles/L Ellman’s reagent in buffer A (50 
mmoles/LTris–HCl containg 0.1 mol/L NaCl and 0.02 mol/L 
MgCl2.6H2O and keep pH 8), 50µL of buffer B (50 mmoles/L 
containing 0.1 % bovine serum albumin keep pH 8), 25µL of 
15 mmoles /L ATCC in water, and 25 µL of herb leaves 
fraction (25 – 400 μg/ mL). After that, AChE (0.2 U/mL) was 
insert to the wells and the absorbance measured by 
microplate reader  ( i Mark Microplate Reader, Bio-Rad 
Laboratories, UK) at 415 nm each 10 sec for 3 mins, for a 
blank with buffer as a substitute of enzyme solution was 
used. Experiments were performed in triplicate. The 
percentage enzyme inhibition was calculated from the rate of 
absorbance alter with time [34]. 
          ( )       
                                     
                          
 
Statistical analysis 
All the results are given as mean ± standard error (SEM). The 
data obtained was analyzed using one-way ANOVA followed 
by Dunnett's t-test. *p <0.05, **p <0.01 were considered 
significant. 
3. RESULTS  
3.1. Phytochemical investigation 
Phytochemical studies of the APEA and APAqs fractions of 
leaves exhibited various phytoconstituent as shown in Table 
1. 
3.2. Acute Toxicity Study  
Both the fraction of A. precatorius was found to be safe up to 
oral administer even with the highest dose (2000 mg/kg). 
Sound responses were no utter sound and vocalization 
noxious stimulus. Touch response and pain response 
touched with a forceps at various parts on the side of the 
neck, groin and abdomen. Their motor activity and grip 
strength were normal and the animals did not show 
staggering gait or contractions.  
3.3. Effect on Elevated plus maze test  
Significant decline in TL value of retention indicated 
improvement in memory. Piracetam (100 mg/kg, p.o.) and 
APEA fraction (150 and 300 mg/kg, p.o.) showed dose-
dependent drop in TL on 7th day and 8th day in mice 
compared to respective control groups induced by 
scopolamine. APEA fraction treated mice showed remarkable 
decrease TL (p < 0.01) in  seventh day as well as eighth day, 
demonstrating notable improvement in memory and 
learning (Table: 2). APAqs fraction (150,300 mg/kg p.o.) do 
not give any significant result in the above parameter.  
3.4. Active avoidance paradigm  
The percentage avoidance response (AR) was evaluated by 
Cook and Weidley’s pole apparatus for evaluating the 
cognitive enhancing activity in both fraction of A. precatorius 
(150 and 300 mg/kg, p.o.) and piracetam (100 mg/kg po). 
Our result showed that APEA fraction and piracetam 
administered for 7 days showed significant dose dependent 
increase in the percentage AR in the TTs as well as in the 
RTs, the results are given in Table: 3. On the other hand, the 
higher doses of APAqs fraction (150, 300 mg/kg p.o.) did not 
exert any significant effect on AR as compared to control 
group. 
3.5. Effect on acetyl cholinesterase activity 
The results obtained from the both fraction and piracetam 
against AChE enzyme showed percentage inhibitory 
activities were evaluated (Figure: 1). APEA fraction showed 
very potent inhibition (91.33±0.33%) at the concentration of 
400 μg/ml when compared with piracetam (94.10 ±0.15%). 
The highest dose of APAqs fraction (400 μg/ml.) did not 
produce any significant inhibition of cholinesterase activity 
(40.34 ± 2.17%).  
4. DISCUSSION 
The present study investigated for the first time the CNS 
effects of methanolic extract of ethyl acetate soluble fractions 
of A. precatorius showed significant cognitive enhancing 
activities evaluated by elevated plus maze (EPM), Cook and 
Weidley’s pole apparatus and assay of AChE enzyme activity. 
In addition to natural process ageing induced amnesia was 
also induced by intraperitoneal injection of scopolamine or 
diazepam in mice. Hence, the possibility of correlating 
performance with altering in the extracellular level of 
neurotransmitters in CNS regions involved in information 
transmission and modulation is immense role in the study of 
memory building. Cognitive dysfunction has been attributed 
due to impairment of acetylcholine neurotransmitter 
functioning. [35]. There are sufficient evidences that support 
central cholinergic system has a vital role in patients of 
memory impairments with the senile dementia [36]. There 
are extensive evidences linking the central cholinergic to 
memory observed reduction in symptoms of AD upon 
chronic use of AChE inhibitors drugs [37]. The cognitive 
enhancer symbolizes a category that initiate the integrative 
functions of the CNS, predominantly learning capacity, 
intellectual performance and memory. The findings from the 
present study are confirmed triterpenoids containing 
ethylacetate fraction of methanol extract boost up effect on 
learning and memory only after action for a period of 7 days. 
Their nootropic potentials claims probably may be attributed 
to the contribution of neurotransmitters augmented only 
when the repeated administration of the ethyl acetate 
fraction. The study reveals dose dependant evidence that the 
central cholinergic system effect in being able to produce 
vital role and even giving a closer comparison with the 
reference drug. [38]. 
Piracetam drug therapy to ameliorate cognitive deficits is a 
nontoxic compound and do not interfere with general 
behavior, limbic system, autonomic functions and level of 
wakefulness etc. The primary representatives of cognitive 
enhancer, piracetam facilitate intellectual performance and 
improve memory in pediatric and geriatric [39]. Recently, 
Itoh verified that the transfer latency of mice to enter in 
enclosed arm from open arm and then exposure of apparatus 
for 10s or more shortened the TL when trial were recurring 
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on 2nd day [40]. Scopolamine, a known muscarinic 
antagonist, displayed temporary loss of memory by 
interfering with cholinergic transmission [41, 42]. In the 
present study, ethyl acetate soluble fractions of A. precatorius 
orally administered for 7 days improved the memory of mice 
as indicated by diminished TL as compared to control 
suggest the possible neuroprotective role. Previous studies 
perform by researchers have exposed that numerous herbal 
plants possess cognitive enhancing drugs like B.monniera 
[43] and A. recemosus [44] including  various Ayurvedic 
formulations such as Anwala churna (E. officinalis) have been 
significant effect to improve memory through amplification 
of CCS function[45]. Active avoidance learning is a 
fundamental behavior phenomenon performed in the Cook 
and Weidley’s pole climbing apparatus. The first stage of 
avoidance rats were initially trained escape the shock by 
climbing onto the wooden pole. Our findings have also 
indicated that both the ethyl acetate fractions as well as 
piracetam provide a significant protection against shock 
consequence in less trials and time to reach the criterion of 
conditioned avoidance learning. Both doses of 150 and 300 
mg/kg of ethyl acetate fractions were administered orally 
successfully reverse amnesia for seven successive potent 
indicating the dose dependent action on cognitive functions. 
Standardized extracts of B. monniera and G. biloba are 
eminent memory enhancers in Indian and Chinese 
traditional medicine systems both show a dose-dependent 
inhibitory effect on AChE activity [46]. In the assay of AChE 
enzyme activity our result indicates significant (91.33±0.33) 
percentage AChE inhibitory activity as compared to 
piracetam. Already, Bhardwaj et al. had reported to separate 
non-glycosidic and glycosidic components of seed kernels of 
A. precatorius was extracted exhaustively with ethanol then 
repeatedly extracted with Diethyl ether and then Ethyl 
acetate solvent [47]. The plant leaves contain sweet-tasting 
unique phytoconstituent are abrusoside A to D and 
abrusogenin, a triterpene  isolated from an n-butanol soluble 
extract of the leaves, as well as abrus agglutinin, 
isoflavanquinones including abruquinones D, E and F 
[48,49]. Preliminary phytochemical studies on ethyl acetate 
fractions rich presence of triterpenoids which have been 
have been reported to have anti-inflammatory activity [50]. 
From the present investigation it was concluded and 
validated the previous research for the utilization of gunchi 
as a nervine tonic in traditional Ayurvedic medicine is not 
invalid. The pharmacological actions of ethyl acetate 
fractions A. precatorius, justify the therapeutic uses 
nootropic activities in the models tested and these effects 
may probably be mediated through augmentation of 
cholinergic system due to its anti-cholinesterase activity. 
Thus, our conclusion validates the traditional claims of A. 
precatorius as a promising cognition boosting herb. 
 
Table: 1 Qualitative analysis of ethyl acetate and aqueous fraction of A. precatorius leaves. 
Phyto  Constituents Phyto chemical Test APEA fractions APAqs fractions 
Carbohydrates Molisch test 
Fehling test 
+ve +ve 
Proteins Biurate test -ve +ve 
Amino acid Million's test -ve +ve 
Tannins Ferric chloride Test -ve +ve 
Alkaloids Hager test 
Wagner test 
+ve 
+ve 
+ve 
+ve 
Saponins Foam test +ve -ve 
Flavonoids Lead acetate test +ve +ve 
Glycosides Hydroxyanthraquinone test +ve -ve 
Steroid Liebermann Burchard test -ve -ve 
Terpenoid Salkowski Test +ve -ve 
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Table: 2 Effect of different fractions of A. precatorius and piracetam on transfer latency of mice on elevated plus maze 
apparatus. 
Groups Treatment Dose 
mg/Kg 
Transfer latency Day 7th   
(sec) 
Transfer latency 
 
Day 8th  
(sec) 
I Positive Control Vehicle p.o. 
 
28.8±0.6 26.3±0.6 
II Negative Control (SCP) 0.4 mg/kg i.p. 42.6±0.8 38.3±0.4 
III Piracetam + SCP 100 mg/kg p.o. 16.5±0.4** 13.5±0.4** 
VI APEA + SCP 150 mg/kg p.o 23.5±.4* 22.3±0.3* 
V 300 mg/kg p.o 20.5±.4** 18.5±0.5** 
VI APAqs + SCP 150 mg/kg p.o 32.4±1.9 30.4±1.9 
VII 300 mg/kg p.o 31.1±3.7 28.1±0.3 
Values are expressed in mean ± SEM (n = 6). *p < 0.05, **p < 0.01 One-way ANOVA followed by Dunnett’s test. 
APEA: E. A. precatorius ethyl acetate fraction, APAqs: A. precatorius aqueous fraction Scopolamine (SCP) 
 
Table: 3 Effect of the different fractions of A. precatorius and piracetam on nootropic activity in rats administered for a period 7 
days using Cook and Weidley’s pole apparatus. 
Group Treatment Dose (mg/kg) 
p.o. 
% Avoidance responses 
in TT (sec) 
% Avoidance  responses 
in RT (sec) 
I Control Vehicle 21.6 ± 3.0 24.1 ± 1.0 
II Piracetam 100 66.6 ± 3.3** 79.2 ± 3.2** 
III APEA 150 45.0 ± 2.2* 59.2 ± 2.2* 
IV 300 60.0 ± 3.6** 73.4 ± 2.1** 
V APAqs 150 28.9 ± 3.1 30.1 ± 3.0 
VI 300 31.2 ± 1.2 33.12± 1.2 
Values are expressed in mean ± SEM (n = 6). *p < 0.05, **p < 0.01 One-way ANOVA followed by Dunnett’s test. 
APEA: A. precatorius ethyl acetate fraction, APAqs: A. precatorius aqueous fraction, TT—training trial, RT—relearning trial. 
 
Fig.:1 Effect of the different fractions of A. precatorius and piracetam percentage inhibition activity of acetylcholinesterase 
(AChE, electric eel) by Ellman’s assay. 
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